News

Filter

Current filters:

None

8176 to 8185 of 96096 results

Patent expiry of key blockbuster drugs good news for generics manufacturers, says F&S

16-01-2012

The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing…

GenericsMarkets & MarketingPatentsPharmaceutical

Two UK product launches

16-01-2012

Danish drugmaker Lundbeck (LUND: DC) announced yesterday that Sycrest (asenapine) is being launched in…

Anti-viralsEuropeIntelenceJanssenJohnson & JohnsonLundbeckMarkets & MarketingNeurologicalPharmaceuticalSaphrisSycrest

Type 1 diabetes discovery by UK scientists

16-01-2012

Scientists in the UK may have uncovered new evidence which it is hoped could eventually help diagnose…

DiabetesPharmaceuticalResearch

Lundbeck manufacturing cost achievements rewarded

16-01-2012

Danish drugmaker Lundbeck A/S (LUND: DC) says it has crowned six years of focused efforts on productivity…

FinancialLundbeckPharmaceutical

FDA completes work on three drug user fee programs

16-01-2012

The US Food and Drug Administration has completed its recommendations for three user fee programs that…

BiotechnologyFinancialGenericsNorth AmericaPharmaceuticalRegulation

“Black box” warning for Seattle Genetics’ Adcetris

16-01-2012

US biotech Seattle Genetics (Nasdaq: SGEN) saw its shares fall 5.2% to $17.49 on Friday, after the company…

AdcetrisBiotechnologyNorth AmericaOncologyRegulationSeattle Genetics

Otsuka Pharma and UCB re-focus collaboration

16-01-2012

Japan’s Otsuka Pharmaceutical (TYO: 4768) and Belgian drugmaker UCB (Euronext Brussels: UCB) have…

Asia-PacificCimziaImmunologicalsKeppraLicensingNeurologicalOtsukaPharmaceuticalResearchrotigotineUCB

Sobi buys rights to novel neonatology treatment

16-01-2012

Stockholm-based Swedish Orphan Biovitrum (STO: SOBI) has signed a global licensing agreement with the…

BumetanideCardio-vascularLicensingNeurologicalOnly for Children PharmaceuticalsPharmaceuticalSwedish Orphan Biovitrum

CVS Caremark settles over deceptive drug pricing

15-01-2012

US pharmacy health care provider CVS Caremark (NYSE: CVS) will pay $5 million to settle Federal Trade…

CVS CaremarkLegalNorth AmericaPharmaceuticalPricing

8176 to 8185 of 96096 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top